13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-13, with 44 holding rows worth $992,161,000.
- Accession
- 0001615774-18-012532
- Filer
- CIK 1674712
- Filed
- 2018-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 44 entries on the cover page, a total value of $992,161,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $992,161,000 with VALUE read as thousands by filing date, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,166,832 | $153,542,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 3,792,169 | $108,646,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 2,049,545 | $76,960,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 2,749,343 | $47,151,000 | thousands by filing date | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 5,900,000 | $44,958,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 2,328,475 | $44,637,000 | thousands by filing date | |
| AMYRIS INC | 03236M200 | COM NEW | 5,575,118 | $44,266,000 | thousands by filing date | |
| MENLO THERAPEUTICS INC | 586858102 | COM | 4,011,236 | $39,511,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 10,454,545 | $34,918,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 991,711 | $30,297,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,359,149 | $30,051,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 1,159,742 | $26,512,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 5,778,106 | $24,904,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,354,554 | $24,084,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,647,214 | $23,918,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 1,791,257 | $21,495,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,492,951 | $18,677,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,405,476 | $18,552,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637105 | SHS | 6,619,190 | $17,872,000 | thousands by filing date | |
| ACER THERAPEUTICS INC | 00444P108 | CMN | 565,579 | $17,442,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 937,147 | $16,897,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 761,253 | $11,837,000 | thousands by filing date | |
| GALMED PHARMACEUTICALS LTD | M47238106 | SHS | 851,492 | $11,563,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 1,043,020 | $10,295,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 906,000 | $10,038,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 620,134 | $9,736,000 | thousands by filing date | |
| SOLENO THERAPEUTIVS, INC. | 834203200 | COMM | 4,359,683 | $9,417,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 212,648 | $8,234,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,213,290 | $8,056,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 264,878 | $6,754,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 8,180,000 | $6,378,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 105,000 | $5,208,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 300,000 | $5,061,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 231,010 | $4,500,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 918,132 | $4,453,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 2,438,270 | $4,145,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 1,728,000 | $3,663,000 | thousands by filing date | |
| BIOPHARMX CORP | 09072X101 | COM | 16,128,515 | $3,064,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 427,500 | $2,450,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 345,850 | $885,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 1,513,975 | $555,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 195,474 | $391,000 | thousands by filing date | |
| GTX INC DEL | 40052B207 | COM NEW | 105,043 | $165,000 | thousands by filing date | |
| SOLENO THERAPEUTICS INC | 834203135 | *W EXP 11/12/201 | 188,772 | $23,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001615774-18-012532 | this filing | 2018-11-13 | acceptance time not in the bulk data set |